Human Medicine
Application |
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
Remarks |
Osteoarthritis
IND submission :
Clinical Trial P1/2
Atopic dermatitis
IND preparation :
Clinical Trial P1/2
Hair loss
Stem Cells Translational Medicine
DOI: 10.1002/sctm.19-0410
Diabetes
The society of korean medicine for obesity research 19(2) : 89-96, 2019
Kidney
Korea academia-Industrial cooperation Society 20(8) : 303-312, 2019
Periodontitis
Korea academia-Industrial cooperation Society 20(6) : 95-103, 2019
Human Medicine
Osteoarthritis
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
IND submission :
Clinical Trial P1/2
Atopic dermatitis
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
IND preparation :
Clinical Trial P1/2
Hair loss
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
Stem Cells Translational Medicine
DOI: 10.1002/sctm.19-0410
Diabetes
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
The society of korean medicine for obesity research 19(2) : 89-96, 2019
Kidney
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
Korea academia-Industrial cooperation Society 20(8) : 303-312, 2019
Periodontitis
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
Korea academia-Industrial cooperation Society 20(6) : 95-103, 2019
Animal Medicine
Application |
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
Remarks |
Arthritis
Approval
Anti-xeroderma
NDA submission
Animal Medicine
Arthritis
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
Approval
Anti-xeroderma
Discovery | Non-Clinical Study |
Clinical Trial P1 |
Clinical Trial P1 |
Clinical Trial P3 |
Approval |
NDA submission